Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorzoxazone vs Orphenadrine Citrate for Bruxism-Related Orofacial Pain
NCT07109882Phase 4Recruiting
- Sponsor
- University of Baghdad
- Start
- Jul 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorzoxazone in Orofacial pain (OFP), bruxism, sponsored by University of Baghdad. Started Jul 2025; status: recruiting.
02
Drugs
chlorzoxazone
03
Conditions
Orofacial pain (OFP)bruxism
Beyond the preview
Go deeper on NCT07109882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07109882.